These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8958390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B, Holm J, Svensson P, Dahlbäck B.
    Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
    [Abstract] [Full Text] [Related]

  • 5. APC resistance in childhood thromboembolism: diagnosis and clinical aspects.
    Nowak-Göttl U, Schneppenheim R, Vielhaber H.
    Semin Thromb Hemost; 1997 Feb; 23(3):253-8. PubMed ID: 9255906
    [Abstract] [Full Text] [Related]

  • 6. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B, Svensson PJ, He X, Dahlbäck B.
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [Abstract] [Full Text] [Related]

  • 7. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction.
    Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Mäkelin R, Hämäläinen L, Palomäki H, Kaste M.
    Thromb Haemost; 1995 Apr; 73(4):558-60. PubMed ID: 7495058
    [Abstract] [Full Text] [Related]

  • 8. Stroke in children: inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients.
    Del Balzo F, Spalice A, Ruggieri M, Greco F, Properzi E, Iannetti P.
    Acta Paediatr; 2009 Jul; 98(7):1130-6. PubMed ID: 19432826
    [Abstract] [Full Text] [Related]

  • 9. Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion.
    Nowak-Göttl U, Binder M, Dübbers A, Kehrel B, Koch HG, Veltmann H, Vielhaber H.
    Thromb Haemost; 1997 Sep; 78(3):1115-8. PubMed ID: 9308763
    [Abstract] [Full Text] [Related]

  • 10. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke.
    Zenz W, Bodó Z, Plotho J, Streif W, Male C, Bernert G, Rauter L, Ebetsberger G, Kaltenbrunner K, Kurnik P, Lischka A, Paky F, Ploier R, Höfler G, Mannhalter C, Muntean W.
    Thromb Haemost; 1998 Nov; 80(5):763-6. PubMed ID: 9843168
    [Abstract] [Full Text] [Related]

  • 11. [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].
    Moia M, La Spina I, Padalino R, Carpenedo M.
    Ann Ital Med Int; 1996 Nov; 11(1):17-9. PubMed ID: 8645525
    [Abstract] [Full Text] [Related]

  • 12. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [Abstract] [Full Text] [Related]

  • 13. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
    Sameiro-Barreirinho M, Costa E, Moreira A, Barbot J, Barbot C, Santos M.
    Rev Neurol; 1995 Jul; 28(11):1061-4. PubMed ID: 10390775
    [Abstract] [Full Text] [Related]

  • 14. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E, Silveira A, van't Hooft F, Tornvall P, Blombäck M, Wiman B, Rydén L, Hamsten A.
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke.
    McColl MD, Chalmers EA, Thomas A, Sproul A, Healey C, Rafferty I, McWilliam R, Eunson P.
    Thromb Haemost; 1999 May; 81(5):690-4. PubMed ID: 10365738
    [Abstract] [Full Text] [Related]

  • 17. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O, Ryan S, Hunter J, Younkin DP.
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [Abstract] [Full Text] [Related]

  • 18. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B, He X, Dahlbäck B.
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [Abstract] [Full Text] [Related]

  • 19. [Resistance to activated protein C. The most common cause of familial thrombophilia].
    Larsen TB, Ravn HB, Lassen JF, Lund ED, Brandslund I.
    Ugeskr Laeger; 1996 Nov 11; 158(46):6584-8. PubMed ID: 8966822
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.
    Ann Hematol; 2004 Nov 11; 83(11):712-5. PubMed ID: 15309526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.